Life stress and losses and deficit in adulthood as breast cancer risk factor: A prospective case-control study in Kuopio, Finland

In Vivo

Volumn 24, Issue 6, 2010, Pages 899-904

  Eskelinen, Matti ^a   Ollonen, Paula ^b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b State Office in Eastern Finland   (Finland)

Author keywords

Breast disease; Psychosocial factors; Stress

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; BREAST DISEASE; CANCER RISK; CLINICAL EXAMINATION; DEPRESSION; FEMALE; FINLAND; HUMAN; LIFE STRESS; MAJOR CLINICAL STUDY; RISK FACTOR; SOCIAL STATUS;

EID: 78650958717     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. McEwen BS: Protective and damaging effects of stress mediators. New Engl J Med 338: 171-179, 1998.
2. McEwen BS: The neurobiology of stress: from serendipity to clinical relevance. Brain Res 886: 172-189, 2000.
3. Key JA, Verkasalo PK and Banks E: Epidemiology of breast cancer. Lancet Oncol 2: 133-140, 2001.
4. Mitrunen K and Hirvonen A: Molecular epidemiology of sporadic breast cancer. The role of polymorphic genes involved in oestrogen biosynthesis and metabolism. Mutat Res 544: 9-41, 2003.
5. Männistö S, Pietinen P, Pyy M, Palmgren J, Eskelinen M and Uusitupa M: Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status. Int J Cancer 68: 8-13, 1996.
6. Mitrunen K, Kataja V, Eskelinen M, Kosma VM, Kang D, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Combined COMT and GST genotypes and hormone replacement therapy associated breast cancer risk. Pharmacogenetics 12: 67-72, 2002.
7. Eskelinen M, Norden T, Lindgren A, Wide L, Adami HO and Holmberg L: Preoperative serum levels of follicle-stimulating hormone (FSH) and prognosis in invasive breast cancer. Eur J Surg Oncology 30: 495-500, 2004.
8. Sillanpää P, Hirvonen A, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H and Mitrunen K: NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Int J Cancer 114: 579-584, 2005.
9. Sillanpää P, Kataja V, Eskelinen M, Kosma V-M, Uusitupa M, Vainio H, Mitrunen K and Hirvonen A: Sulfotransferase 1A1 genotype as a potential modifier of breast cancer risk among premenopausal women. Pharmacogenetics 15: 749-752, 2005.
10. Chen CC, David AS, Nunnerley H, Michell M, Dawson JL, Berry H, Dobbs J and Fahy T: Adverse life events and breast cancer: case-control study. BMJ 311: 1527-1530, 1995.
11. Roberts FD, Newcomb PA, Trentham-Dietz A and Storer BE: Self-reported stress and risk of breast cancer. Cancer 77: 1089-1093, 1996.
12. McKenna MC, Zevon MA, Corn B and Rounds J: Psychosocial factors and the development of breast cancer: a meta-analysis. Health Psychol 18: 520-531, 1999.
13. Protheroe D, Turvey K, Horgan K, Benson E, Bowers D and House A: Stressful life events and difficulties and onset of breast cancer: case-control study. BMJ 319: 1027-1030, 1999.
14. Price MA, Tennant CC, Butow PN, Smith RC, Kennedy SJ, Kossoff MB and Dunn SM: The role of psychosocial factors in the development of breast carcinoma: Part II. Life event stressors, social support, defense style, and emotional control and their interactions. Cancer 91: 686-697, 2001.
15. Duijts SFA, Zeegers MPA and VD Borne B: The association between stressful life events and breast cancer risk: a meta-analysis. Int J Cancer 107: 1023-1029, 2003.
16. Ginzburg K, Wrensch M, Rice T, Farren G and Spiegel D: Breast cancer and psychosocial factors: Early stressful life events, social support, and well-being. Psychosomatics 49: 407-412, 2008.
17. Ollonen P, Lehtonen J and Eskelinen M: Stressful and adverse life experiences in patients with breast symptoms; a prospective case-control study in Kuopio, Finland. Anticancer Res 25: 531-536, 2005.
18. Ollonen P, Lehtonen J and Eskelinen M: Anxiety, Depression and the history of psychiatric symptoms in patients with breast disease: A prospective case-control study in Kuopio, Finland. Anticancer Res 25: 2527-2534, 2005.
19. Ollonen P, Lehtonen J and Eskelinen M: Coping and defending as risk factors for breast cancer in patients with breast disease; a prospective case-control study in Kuopio, Finland. Anticancer Res 25: 4623-4630, 2005.
20. Ollonen P and Eskelinen M: Idealization as risk factor for breast cancer in patients with breast disease - a prospective case-control study in Kuopio, Finland. Anticancer Res 27: 1625-1630, 2007.
21. Eskelinen M and Ollonen P: Psychosocial risk scale (PRS) for breast cancer in patients with breast disease: A prospective case-control study in Kuopio, Finland. Anticancer Res 29: 4765-4770, 2009
22. Eskelinen M and Ollonen P: The body image drawing analysis in women with breast disease and breast cancer: anxiety, colour and depression categories. Anticancer Res 30: 683-691, 2010.
23. Eskelinen M and Ollonen P: Evaluation of women with breast disease using body image drawing analysis. Anticancer Res 30: 2399-2406, 2010.
24. Forsen A: Psychosocial stress as a risk for breast cancer. Psychother Psychosom 55: 176-185, 1991.
25. Cooper CL and Faragher EB: Psychosocial stress and breast cancer: the interrelationship between stress events, coping strategies and personality. Psychol Med 23: 653-662, 1993.
26. Boyle P: SEARCH programme of the International Agency for Research on Cancer. Eur J Cancer 26: 547-549, 1990.
27. Eskelinen M, Collan Y, Leivonen M, Hertsi M, Valkamo E, Puittinen J and Karosto R: Detection of breast cancer. A study of women with breast cancer symptoms. Theor Surg 3: 111-117, 1988.
28. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Steroid metabolism gene CYP17 polymorphism and the development of breast cancer. Cancer Epidemiol Biomarkers Prev 9: 1343-1348, 2000.
29. Mitrunen K, Jourenkova N, Kataja V, Eskelinen M, Kosma VM, Benhamou S, Vainio H, Uusitupa M and Hirvonen A: Glutathione-S-transferase M1, M3, P1 and T1 genetic polymorphism and susceptibility to breast cancer. Cancer Epidemiol Biomarkers Prev 10: 229-236, 2001.
30. Haan N: Coping and Defending Process of Self-environment Organization. New York, Academic Press, 1977.
31. Beck AT, Ward CH, Mendelson M, Mock J and Erbaugh J: An inventory for measuring depression. Arch Gen Psych 4: 53-61, 1961.
32. Beck AT, Steer RA and Garbin MG: Psychometric properties of the Beck depression inventory: Twenty-five years of evaluation. Clin Psychol Rev 8: 77-100, 1988.
33. Spielberger CD: Manual for the State-Trait Anxiety Inventory STAI (Form Y) (Self-evaluation questionnaire). Palo Alto, CA, Consulting Psychologists Press, 1983.
34. Montgomery SA and Åsberg M: A new depression scale designed to be sensitive to change. Br J Psych 134: 322-389, 1979.
35. Reiche EMV, Vargas Nunes S and Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncology 5: 617-625, 2004.
36. Johnston-Brooks CH, Lewis MA, Evans GW and Whalen CK: Chronic stress and Illness in children: The role of allostatic load. Psychosom Med 60: 597-603, 1998.
37. Holmes TH and Rahe RH: The social readjustment rating scale. J Psychosom Res 2: 213-218, 1967.
38. McGee R: Does stress cause cancer? There is no good evidence of a relation between stressful events and cancer. BMJ 319: 1015-1016, 1999.